ClinicalTrials.Veeva

Menu

A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children

Pfizer logo

Pfizer

Status and phase

Completed
Phase 2
Phase 1

Conditions

Neutropenia

Treatments

Drug: Voriconazole

Study type

Interventional

Funder types

Industry

Identifiers

NCT00174473
A1501037

Details and patient eligibility

About

This is a study to investigate the pharmacokinetics, safety and tolerability of several doses of voriconazole, intravenous and oral suspension formulations, in children

Enrollment

49 patients

Sex

All

Ages

2 to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Children who require a systemic antifungal agent for the prevention of systemic fungal infection

Exclusion criteria

  • Children who are receiving medications which cannot be taken concomitantly with voriconazole.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems